We focused our study on the hypothesis of the effects of the combination of monensin and rapamycin on apoptosis of xenograft neuroblastoma tumor cells in vivo and the role of the PI3K/AKT/mTOR pathway on this development in an advanced preclinical stage. The gene discussed is AKT1; the disease is neoplasm.